Two new antibody assays developed and validated at Cincinnati Children’s are helping lab staff save costs on the rising frequency of COVID-19 serology testing–and are now available to the regional medical community.
The tests can be ordered via Epic link or via a downloadable PDF.
“We have now made COVID-19 serology available locally in-house in our clinical nephrology laboratory for rapid resulting and for a fraction of the cost of commercial assays,” says Prasad Devarajan, MD, Director, Division of Nephrology and Hypertension.
Now, clinicians and lab staff have three antibody testing options:
“These new tests were developed and validated here by a multidisciplinary Research Foundation team. Many thanks for the hard work put forth by these team members who were motivated by a desire to make a local and regional impact on the fight against the pandemic,” says Paul Steele, MD, Medical Director of the Core Clinical Lab at Cincinnati Children’s.
Questions about the two new tests can be directed to the Clinical Nephrology lab at 513-636-4530.
The Research Horizons blog features news and insights about the latest discoveries and innovations developed by the scientists of Cincinnati Children's. This blog does not provide medical advice, diagnosis, or treatment.